Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome

Donato Rigante, Giuseppe Lopalco, Antonio Vitale, Orso Maria Lucherini, Caterina De Clemente, Francesco Caso, Giacomo Emmi, Luisa Costa, Elena Silvestri, Laura Andreozzi, Florenzo Iannone, Mauro Galeazzi, Luca Cantarini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

46 Citazioni (Scopus)


Tumor necrosis factor receptor-associated periodic syndrome (TRAPS), formerly known as familial Hibernian fever, is the most common autosomal dominant autoinflammatory disease, resulting from mutations in the TNFRSF1A gene, encoding the 55-kD tumor necrosis factor receptor. The pathophysiologic mechanism of TRAPS remains ambiguous and only partially explained. The onset age of the syndrome is variable and the clinical scenery is characterized by recurrent episodes of high-grade fever that typically lasts 1-3 weeks, associated with migrating myalgia, pseudocellulitis, diffuse abdominal pain, appendicitis-like findings, ocular inflammatory signs, and risk of long-term amyloidosis. Fever episodes are responsive to high-dose corticosteroids, but different classes of drugs have been reported to be ineffective. The use of etanercept is unable to control systemic inflammation, while interleukin-1 blockade has been shown as effective in the control of disease activity in many patients reported so far.
Lingua originaleEnglish
pagine (da-a)1197-1207
Numero di pagine11
RivistaClinical Rheumatology
Stato di pubblicazionePubblicato - 2014


  • Interleukin-1
  • Tumor necrosis factor-receptor-associated periodic syndrome


Entra nei temi di ricerca di 'Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome'. Insieme formano una fingerprint unica.

Cita questo